Xu U Wu

age ~49

from Lexington, MA

Get Report

Also known as:

Xiao Lan Wu
Xiaolan Wu
Xu Wang
Wu Xu

Phone and address:: 15 Solomon Pierce Rd, Lexington, MA 02420

Connected to:

Xu Wu Phones & Addresses

15 Solomon Pierce Rd, Lexington, MA 02420
Cambridge, MA
San Diego, CA
4400 Spruce St, Philadelphia, PA 19104 • 2153820808 • 2153825283 • 2153879850

Work

Company:

Chous consolidated enterprise
Address:

P.o. Box 414, Conshohocken, PA 19428
Phones:

7183538818
Position:

Manager
Industries:

Real Estate Agents and Managers

Name / Title

Company / Classification

Phones & Addresses

Xu Zeng Wu
Manager

Chous Consolidated Enterprise
Real Estate Agents and Managers

P.o. Box 414, Conshohocken, PA 19428

Resumes

Assistant Professor

view source

Location:

1304 west Green St, Urbana, IL 61802

Industry:

Higher Education

Work:

North Carolina State University
Assistant Professor
University of Illinois at Urbana-Champaign Jan 2012 - Oct 2017
Research Assistant
Massachusetts Institute of Technology (Mit) Jan 2012 - Oct 2017
Postdoctoral Associate

Education:

University of Illinois at Urbana - Champaign 2011 - 2017
Doctorates, Doctor of Philosophy, Philosophy, Nuclear Engineering University of Illinois at Urbana - Champaign 2013
Master of Science, Masters University of Illinois at Urbana - Champaign 2011 - 2013
Masters, Engineering, Nuclear Engineering Shanghai Jiao Tong University 2007 - 2011
Bachelors, Bachelor of Science, Nuclear Engineering

Skills:

Statistical Modeling
Markov Chain Monte Carlo
Bayesian Inference
Uncertainty Quantification
Numerical Analysis
Mathematical Modeling
Monte Carlo Simulation
Matlab
Spectral Analysis
Latex
Reactor Physics
Nuclear Safety
Computational Physics
Mathematica
Fortran
Data Analysis
C++
Labview

Languages:

English
Mandarin

Xu Yang Wu

view source

Research Assistant At The New York Blood Center

view source

Position:

Research Assistant at The New York Blood Center

Location:

United States

Industry:

Hospital & Health Care

Work:

The New York Blood Center
Research Assistant

Us Patents

Compositions And Methods For Inducing Osteogenesis
view source
US Patent:

7273864, Sep 25, 2007
Filed:

Oct 15, 2003
Appl. No.:

10/687220
Inventors:

Xu Wu - San Diego CA, US
Sheng Ding - San Diego CA, US
Nathanael S. Gray - San Diego CA, US
Assignee:

The Scripps Research Institute - La Jolla CA
International Classification:

C07D 473/40
C07D 473/34
C07D 473/18
A61K 31/522
A61K 31/52
US Classification:

5142342, 51426337, 51426338, 5142634, 544118, 544276, 544277
Abstract:

The present invention provides compositions and methods for differentiating and transdifferentiating mammalian cells into cells of an osteoblast lineage, using compounds of the following formula:.

Compounds And Compositions As Hedgehog Pathway Modulators
view source
US Patent:

8178563, May 15, 2012
Filed:

May 4, 2007
Appl. No.:

12/299290
Inventors:

Wenqi Gao - San Diego CA, US
Jiqing Jiang - San Diego CA, US
Yongqin Wan - Irvine CA, US
Dai Cheng - San Diego CA, US
Dong Han - San Diego CA, US
Xu Wu - San Diego CA, US
Shifeng Pan - San Diego CA, US
Assignee:

IRM LLC - Hamilton
International Classification:

A61K 31/44
C07D 213/72
US Classification:

514352, 546304
Abstract:

The invention provides a method for modulating the activity of the hedgehog signaling pathway. In particular, the invention provides a method for inhibiting aberrant growth states resulting from phenotypes such as Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-function or Gli gain-of-function, comprising contacting a cell with a sufficient amount of a compound of Formula I.

Pyrido [4, 3-D] Pyrimidinone Derivatives As Kinase Inhibitors
view source
US Patent:

8354526, Jan 15, 2013
Filed:

Jan 27, 2009
Appl. No.:

12/865367
Inventors:

Qiang Ding - San Diego CA, US
Yahua Liu - San Diego CA, US
Xu Wu - San Diego CA, US
Qihui Jin - San Diego CA, US
Jianwei Che - San Diego CA, US
S. Frank Yan - Shanghai, CN
Assignee:

IRM LLC - Hamilton
International Classification:

C07D 345/00
US Classification:

540 1
Abstract:

The invention provides a class of compounds of Formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Syk, ZAP70, KDR, FMS, FLT3, c-Kit, RET, TrkA, TrkB, TrkC, IGR-IR, AIk, c-FMS, or combinations thereof.

Biphenylcarboxamide Derivatives As Hedgehod Pathway Modulators
view source
US Patent:

8507471, Aug 13, 2013
Filed:

Jun 4, 2008
Appl. No.:

12/663490
Inventors:

Christine Dierks - Freiburg, DE
Markus Warmuth - Natick MA, US
Xu Wu - San Diego CA, US
Assignee:

IRM LLC - Hamilton
International Classification:

A01N 43/00
US Classification:

51421115, 51421704, 5142382, 435375
Abstract:

The invention provides a method for modulating the activity of the hedgehog signaling pathway. In particular, the invention provides a method for inhibiting aberrant growth states resulting from phenotypes such as Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-function or Gli gain-of-function, comprising contacting a cell with a sufficient amount of a compound of Formula I.

Compositions And Methods For Inducing Cardiomyogenesis
view source
US Patent:

20050209231, Sep 22, 2005
Filed:

Jan 14, 2005
Appl. No.:

11/035708
Inventors:

Xu Wu - San Diego CA, US
Sheng Ding - San Diego CA, US
Peter Schultz - La Jolla CA, US
International Classification:

A61K031/5377
A61K031/506
C07D413/02
C07D043/02
US Classification:

514235500, 514275000, 544122000, 544294000, 544324000
Abstract:

The present invention provides compositions and methods for inducing cardiomyogenesis in mammalian cells, particularly embryonic stem cells, in vitro and in vivo.

Compositions And Methods For Inducing Osteogenesis
view source
US Patent:

20080214541, Sep 4, 2008
Filed:

Sep 20, 2007
Appl. No.:

11/858827
Inventors:

Xu Wu - San Diego CA, US
Sheng Ding - San Diego CA, US
Nathanael S. Gray - San Diego CA, US
Assignee:

IRM LLC - Hamilton HM LX
Scripps Research Institute - La Jolla CA
International Classification:

A61K 31/5377
C07D 473/00
A61K 31/52
C12Q 1/02
C12Q 1/68
C12N 5/00
C07D 295/00
US Classification:

5142342, 544277, 5142631, 544118, 435377, 435354, 435 29, 435 6, 435352, 435363, 435366
Abstract:

The present invention provides compositions and methods for differentiating and transdifferentiating mammalian cells into cells of an osteoblast lineage.

Compounds And Compositions As Hedgehog Pathway Modulators
view source
US Patent:

20090209573, Aug 20, 2009
Filed:

Oct 28, 2005
Appl. No.:

11/718226
Inventors:

Xu Wu - San Diego CA, US
Sheng Ding - San Diego CA, US
Peter G. Schultz - La Jolla CA, US
Assignee:

IRM LLC - Hamilton
THE SCRIPPS RESEARCH INSTITUTE - La Jolla CA
International Classification:

A61K 31/437
C12N 5/06
A61K 31/427
US Classification:

514300, 435375, 514371
Abstract:

The invention provides a method for modulating the activity of the hedgehog signaling pathway. In particular, the invention provides a method for inhibiting aberrant growth states resulting from phenotypes such as Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-function or Gli gain-of-function, comprising contacting a cell with a sufficient amount of a compound of Formula I.

Compounds And Compositions As Kinase Inhibitors
view source
US Patent:

20110003798, Jan 6, 2011
Filed:

Jan 27, 2009
Appl. No.:

12/865339
Inventors:

Barun Okram - San Diego CA, US
Tetsuo Uno - San Diego CA, US
Qiang Ding - San Diego CA, US
Yahua Liu - San Diego CA, US
Yunho Jin - San Diego CA, US
Qihui Jin - San Diego CA, US
Xu Wu - San Diego CA, US
Jianwei Che - San Diego CA, US
S. Frank Yan - Shanghai, CN
Xueshi Hao - San Diego CA, US
Assignee:

IRM LLC - Hamilton
International Classification:

A61K 31/5415
C07D 471/04
C07D 498/04
A61K 31/4375
A61K 31/5377
A61K 31/506
A61K 31/496
A61K 31/541
A61K 31/497
A61K 31/538
A61K 31/5383
A61K 31/501
A61P 11/06
A61P 11/08
A61P 11/00
A61P 17/00
A61P 17/06
A61P 11/02
A61P 29/00
A61P 25/00
A61P 35/00
A61P 31/18
A61P 37/02
US Classification:

5142242, 546122, 544122, 544127, 544318, 544333, 544123, 544362, 544 80, 544121, 544405, 544 582, 544120, 544 52, 544105, 546118, 546121, 544238, 544331, 514300, 5142325, 5142345, 514256, 51425304, 5142282, 51425505, 51425218, 5142305, 5142332, 51425204, 514275
Abstract:

The invention provides a novel class of 2,7-naphthyridin derivatives; pharmaceutical compositions comprising such compounds and methods of using such compounds to treat o prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Syk, ZAP70, KDR, FMS, FLT*, c-Kit, RET, TrkA, TrkB, TrkC-GR-1R, Alk, c-FMS or combinations thereof.